High Amount of PD-L1+Tumor Associated Macrophages Is Associated with Better Survival in Patients with Primary Testicular Lymphoma

被引：0
|
作者：
Pollari, Marjukka
Bruck, Oscar
Leivonen, Suvi-Katri
Pellinen, Teijo
Vahamurto, Pauli
Karjalainen-Lindsberg, Marja-Liisa
Mannisto, Susanna
Kellokumpu-Lehtinen, Pirkko-Liisa
Mustjoki, Satu
Leppa, Sirpa
机构：
来源：
BLOOD | 2017年 / 130卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2761
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Roles of tumor-associated macrophages in anti-PD-1/PD-L1 immunotherapy for solid cancers
    Zhang, Hao
    Liu, Lin
    Liu, Jinbo
    Dang, Pengyuan
    Hu, Shengyun
    Yuan, Weitang
    Sun, Zhenqiang
    Liu, Yang
    Wang, Chengzeng
    MOLECULAR CANCER, 2023, 22 (01)
  • [32] Expression of PSMA in Tumor-Associated Vasculature Predicts Poorer Survival in Patients With Hepatocellular Carcinoma and Is Likely Associated With PD-L1
    Li, Rena X.
    Hao, Yansheng
    Ettel, Mark
    INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY, 2024, 32 (07) : 1248 - 1255
  • [33] High Expression of PD-L1 Is Associated with Better Survival in Pancreatic/Periampullary Cancers and Correlates with Epithelial to Mesenchymal Transition
    Thakur, Nishant
    Paik, Kwang Yeol
    Hwang, Gyoyeon
    Chong, Yosep
    DIAGNOSTICS, 2021, 11 (04)
  • [34] Increased tumor vascularization is associated with the amount of immune competent PD-1 positive cells in testicular germ cell tumors
    Jennewein, Lukas
    Bartsch, Georg
    Gust, Kilian
    Kvasnicka, Hans-Michael
    Haferkamp, Axel
    Blaheta, Roman
    Mittelbronn, Michel
    Harter, Patrick N.
    Mani, Jens
    ONCOLOGY LETTERS, 2018, 15 (06) : 9852 - 9860
  • [35] Reprogramming of PD1+M2-like tumor-associated macrophages with anti-PD-L1 and Lenalidomide in cutaneous T cell lymphoma.
    Han, Zhen
    Su, Chingyu
    Wu, Xiwei
    Qin, Hanjun
    Rosen, Steven T.
    Querfeld, Christiane
    CANCER RESEARCH, 2021, 81 (13)
  • [36] Role of tumor-associated macrophages in esophageal cancer: PD-L1 expression and prognosis
    Yagi, Taisuke
    Baba, Yoshifumi
    Koga, Yuki
    Uchihara, Tomoyuki
    Kiyozumi, Yuki
    Sawayama, Hiroshi
    Hiyoshi, Yukiharu
    Iwatsuki, Masaaki
    Miyamoto, Yuji
    Yoshida, Naoya
    Baba, Hideo
    CANCER RESEARCH, 2018, 78 (13)
  • [37] A high M1/M2 ratio of tumor-associated macrophages is associated with extended survival in ovarian cancer patients
    Zhang, Meiying
    He, Yifeng
    Sun, Xiangjun
    Li, Qing
    Wang, Wenjing
    Zhao, Aimin
    Di, Wen
    JOURNAL OF OVARIAN RESEARCH, 2014, 7
  • [38] The mechanisms of PD-L1 overexpression in tumor associated macrophages (TAMs) in lung and breast cancers
    Komohara, Yoshihiro
    Shinchi, Yusuke
    Yonemitsu, Kimihiro
    Fujiwara, Yukio
    Yamamoto, Yutaka
    Suzuki, Makoto
    CANCER SCIENCE, 2023, 114 : 585 - 585
  • [39] A high M1/M2 ratio of tumor-associated macrophages is associated with extended survival in ovarian cancer patients
    Meiying Zhang
    Yifeng He
    Xiangjun Sun
    Qing Li
    Wenjing Wang
    Aimin Zhao
    Wen Di
    Journal of Ovarian Research, 7
  • [40] Combination therapy using PERK and PD1/PD-L1 inhibitors reprograms tumor associated macrophages and reduces tumor burden
    Kumar, Sushil
    McCane, Michael
    Drees, Jeremy
    Bose, Nandita
    Coussens, Lisa
    CANCER RESEARCH, 2023, 83 (07)
12345